Mandalay Resorts Soars on MGM Bid

ImClone rises; Landry's Restaurant CFO steps down; plus more of today's stocks in the news

ImClone Systems (IMCL ) shares surged after the company said its Erbitux medicine helped patients with head and neck cancers live twice as long as those getting standard treatment. ImClone is developing the drug with Germany's Merck KGaA Merck KGaA and Brisol-Myers (BMY ). Citigroup upgraded to buy from hold. S&P keeps buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.